PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Company ReportsKAI Pharmaceuticals
KAI Pharmaceuticals
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Loading
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
ParsabivEtelcalcetide2017-02-072030-2034
Secondary hyperparathyroidism
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Etelcalcetide
bone diseases
,
chronic kidney disease-mineral and bone disorder
,
chronic kidney failure
,
vascular calcification
,
calcinosis
,
neoplasm metastasis
,
secondary hyperparathyroidism
,
hyperparathyroidism
,
chronic renal insufficiency
,
kidney diseases
,
left ventricular hypertrophy
,
cardiomegaly
,
hypertrophy
,
renal dialysis
Benzocaine
anxiety disorders
,
healthy volunteers/patients
,
huntington disease
,
non-alcoholic fatty liver disease
,
overweight
,
fatty liver
,
hepatitis b
,
syndrome
,
breast neoplasms
,
neoplasms
,
chronic hepatitis b
,
chronic hepatitis
,
parkinson disease
,
eosinophilic esophagitis
,
pruritus
,
biliary liver cirrhosis
,
cholestasis
,
asthma
,
pulmonary hypertension
,
pulmonary arterial hypertension
,
diffuse scleroderma
,
sclerosis
,
myalgia
,
liver diseases
,
short bowel syndrome
,
myocardial infarction
,
drug resistance
,
heat stress disorders
,
mood disorders
,
combat disorders
,
traumatic stress disorders
,
gastrointestinal diseases
,
constipation
,
intestinal diseases
,
knee osteoarthritis
,
pain
,
osteoarthritis
,
musculoskeletal diseases
,
urinary bladder neoplasms
,
transitional cell carcinoma
,
depressive disorder
,
hepatitis
,
depression
,
major depressive disorder
,
hepatitis a
,
arthritis
,
anemia
,
kidney diseases
,
hepatitis c
,
cardiovascular diseases
,
chronic renal insufficiency
,
chronic hepatitis c
,
papillomavirus infections
,
hypertension
,
inflammation
,
pulmonary embolism
,
embolism
,
thromboembolism
,
thrombosis
,
venous thrombosis
,
infections
,
papillomavirus vaccines
,
meningitis
,
meningococcal infections
,
heart failure
,
glucose metabolism disorders
,
metabolic diseases
,
vascular diseases
,
heart diseases
,
metabolic syndrome
,
endocrine system diseases
,
hypertriglyceridemia
,
rheumatoid arthritis
,
atrial fibrillation
,
type 2 diabetes mellitus
,
diabetes mellitus
,
myositis
,
systemic scleroderma
,
juvenile arthritis
,
behcet syndrome
,
dermatomyositis
,
ankylosing spondylitis
,
sjogren's syndrome
,
systemic lupus erythematosus
,
herpes zoster
,
spondylarthritis
,
systemic vasculitis
,
diabetic neuropathies
,
hypercholesterolemia
,
facial pain
,
facial nerve diseases
,
facies
,
wasting syndrome
,
cachexia
,
keratoconjunctivitis sicca
,
dry eye syndromes
DELCASERTIB
cardiovascular diseases
,
myocardial infarction
,
infarction
,
pathologic processes
Histone-arginine methyltransferase carm1
heart failure
,
chronic renal insufficiency
,
edema
,
iron overload
,
hypernatremia
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use